Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Psoriasis: HELP
Articles by O. D. van Cranenburgh
Based on 3 articles published since 2010
(Why 3 articles?)

Between 2010 and 2020, O. D. van Cranenburgh wrote the following 3 articles about Psoriasis.
+ Citations + Abstracts
1 Guideline Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011. Dutch Society of Dermatology and Venereology. 2014

Zweegers, J / de Jong, E M G J / Nijsten, T E C / de Bes, J / te Booij, M / Borgonjen, R J / van Cranenburgh, O D / van Deutekom, H / van Everdingen, J J E / de Groot, M / Van Hees, C L M / Hulshuizen, H / Koek, M B G / de Korte, W J A / de Korte, J / Lecluse, L L A / Pasch, M C / Poblete-Gutiérrez, P A / Prens, E P / Seyger, M M B / Thio, H B / Torcque, L A / de Vries, A C Q / van de Kerkhof, P C M / Spuls, Ph I. ·Dutch Society of Dermatology and Venereology. j.zweegers@derma.umcn.nl. ·Dermatol Online J · Pubmed #24656281.

ABSTRACT: This document provides a summary of the Dutch S3-guidelines on the treatment of psoriasis. These guidelines were finalized in December 2011 and contain unique chapters on the treatment of psoriasis of the face and flexures, childhood psoriasis as well as the patient's perspective on treatment. They also cover the topical treatment of psoriasis, photo(chemo)therapy, conventional systemic therapy and biological therapy.

2 Article Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017. 2019

van der Kraaij, G E / Balak, D M W / Busard, C I / van Cranenburgh, O D / Chung, Y / Driessen, R J B / de Groot, M / de Jong, E M G J / Kemperman, P M J H / de Kort, W J A / Karsch, S A / Lamberts, A / Lecluse, L L A / van Lümig, P P M / Menting, S P / Prens, E P / van den Reek, J M P A / Seyger, M M B / Thio, H B / Veldkamp, W R / Wakkee, M / Nast, A / Jacobs, A / Rosumeck, S / Spuls Chair, P I. ·Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. · Public Health, Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. · Dutch Society of Dermatology and Venereology, Utrecht, the Netherlands. · University Medical Centre Utrecht, Utrecht, the Netherlands. · Dutch Skin Foundation, Nieuwegein, the Netherlands. · Radboud University Medical Centre, Nijmegen, the Netherlands. · Antonius Hospital, Sneek/Emmeloord, the Netherlands. · Radboud University Nijmegen, the Netherlands. · Waterlandziekenhuis, Purmerend, the Netherlands. · Amphia Hospital, Breda, the Netherlands. · University Medical Center Groningen, Groningen, the Netherlands. · Bergman Clinics and U-clinic, Amsterdam, the Netherlands. · Erasmus Medical Centre, Rotterdam, the Netherlands. · Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. ·Br J Dermatol · Pubmed #30604536.

ABSTRACT: -- No abstract --

3 Article Satisfaction with treatment among patients with psoriasis: a web-based survey study. 2013

van Cranenburgh, O D / de Korte, J / Sprangers, M A G / de Rie, M A / Smets, E M A. ·Department of Dermatology, University of Amsterdam, AZ Amsterdam, The Netherlands. o.d.vancranenburgh@amc.uva.nl ·Br J Dermatol · Pubmed #23565643.

ABSTRACT: BACKGROUND: Various psoriasis treatments are currently available: topical therapy, photo(chemo)therapy, oral agents and biologics. Little is known about patients' satisfaction with these treatment options. Moreover, the few available studies show methodological shortcomings. OBJECTIVES: To answer the following questions: firstly, how satisfied are patients with psoriasis with their current treatment and does patients' satisfaction significantly differ between treatment types when controlling for demographic and clinical factors? Secondly, how important are specific domains of satisfaction to patients, and when taking perceived importance into account, which domains merit the most attention in improving quality of care? METHODS: Members of the two existing Dutch associations for patients with psoriasis were invited to complete a web-based survey, which included a study-specific satisfaction questionnaire. RESULTS: A total of 1293 patients completed the survey (response rate 32%). Overall, patients were moderately satisfied with their current treatment. Patients receiving topical treatment were significantly least satisfied; patients receiving biologic treatment were significantly most satisfied. Overall, patients rated 'treatment effectiveness' as most important, followed by 'treatment safety' and 'doctor-patient communication'. Domains with the highest 'room for improvement' scores were effectiveness of topical therapy, phototherapy and oral agents (but not biologic treatment), convenience of topical treatment and safety of systemic treatments (both oral agents and biologics). CONCLUSIONS: From the perspective of patients, biologic treatment is promising. To improve further the quality of psoriasis care, the effectiveness and convenience of topical therapies, the safety of systemic therapies, and doctors' communication skills need to be addressed.